8,517 articles
Keersten Ricks
Keersten Ricks is an American infectious-disease diagnostician and epidemiologist at USAMRIID known for immunoassay-based biosurveillance of emerging diseases and a 2025 Presidential Early Career Award.
Keertan Dheda
Keertan Dheda is a South African pulmonologist and tuberculosis researcher who heads pulmonology at the University of Cape Town and Groote Schuur Hospital and directs its Centre for Lung Infection and Immunity.
Keiichi I. Nakayama
Keiichi I. Nakayama (中山敬一) is a Japanese cancer biologist at Kyushu University and Institute of Science Tokyo known for p27 knockout mice and ubiquitin ligases.
Keisuke Nagao
Keisuke Nagao (永尾 圭介) is a Japanese physician-scientist who studies how hair follicles organize skin immunity and became dermatology chair at Keio University in 2026.
Keith A. Hruska
Keith A. Hruska is an American nephrologist and professor of pediatrics, medicine, and cell biology at Washington University in St. Louis, known for work on the CKD-mineral bone disorder.
Keith A. Josephs
Keith A. Josephs (Keith Josephs) is a neurologist and Professor of Neurology at Mayo Clinic in Rochester, Minnesota, known for reclassifying progressive supranuclear palsy and frontotemporal dementia.
Keith A.A. Fox
Keith A.A. Fox is a British cardiologist who held the Duke of Edinburgh Professorship of Cardiology at the University of Edinburgh and led trials shaping acute coronary syndrome treatment.
Keith B. Elkon
Keith B. Elkon is an immunologist and rheumatologist who led the University of Washington Division of Rheumatology from 2001 to 2021 and is known for lupus research on antiribosomal P antibodies and clearance of dying cells.
Keith C. Norris
Keith C. Norris is an American nephrologist at UCLA who studies chronic kidney disease, hypertension, and health disparities, and was elected to the National Academy of Medicine in 2021.
Keith Cohn
Keith E. Cohn is an American cardiologist known for a 1976 NEJM paper defining variant angina with normal coronary arteriogram, and 1974 work on dialysis hypotension.
Keith D. Lindor
Keith D. Lindor is an American hepatologist known for clinical trials in liver disease and former dean of the College of Health Solutions at Arizona State University.
Keith Hawton
Keith Hawton, born in 1942, is a British psychiatrist and suicidologist who founded Oxford's Centre for Suicide Research; his work on paracetamol pack-size limits helped cut poisoning deaths by 43%.
Keith M. Channon
Keith M. Channon is a British cardiologist and professor of cardiovascular medicine at Oxford, known for research on nitric oxide, coronary heart disease genetics, and the QR4 risk algorithm.
Keith P. Klugman
Keith P. Klugman is a South African-trained infectious-diseases epidemiologist and physician who directs the Pneumonia program at the Bill & Melinda Gates Foundation and led the first phase III pneumococcal vaccine trial in Africa.
Keith T. Flaherty
Keith T. Flaherty is an American medical oncologist who directs clinical cancer research at Mass General Cancer Center and pioneered targeted therapies for melanoma, including vemurafenib.
Kelle Harbert Moley
Kelle H. Moley is a reproductive endocrinologist elected to the National Academy of Medicine in 2014, known for research on metabolism, oocyte aging, and fertility.
Kelley Lee
Kelley Lee is a professor and Tier 1 Canada Research Chair in Global Health Governance at Simon Fraser University, whose tobacco industry research informed the WHO tobacco treaty.
Kelly D. Brownell
Kelly D. Brownell is an American public-health researcher at Duke University known for obesity prevention research and for arguing that food taxes, not willpower alone, are needed.
Kelly E. Mayo
Kelly E. Mayo is an American molecular endocrinologist known for cloning the human growth hormone-releasing factor cDNA in 1983 and for serving as president of the Endocrine Society.
Kelly N. Botteron
Kelly N. Botteron is an American child and adolescent psychiatrist and neuroimaging researcher, professor of psychiatry and radiology at Washington University School of Medicine in St. Louis.
Ken Cadwell
Ken Cadwell (K. Cadwell) is an immunologist who studies how gut viruses and bacteria interact with the immune system, known for showing viruses act as gut microbiome members.
Ken Chen
Ken Chen is a computational biologist and Professor of Bioinformatics and Computational Biology at the University of Texas MD Anderson Cancer Center, known for widely used cancer genomics tools including BreakDancer, VarScan, and Monovar.
Ken S. Lau
Ken S. Lau (Ken Lau) is a molecular biologist at Vanderbilt University School of Medicine who studies how colorectal cancer begins and evolves using single-cell and spatial mapping.
Kenji Kabashima
Kenji Kabashima (椛島 健治) is a Japanese dermatologist and immunologist, professor and chair of dermatology at Kyoto University, known for research on skin immunity and nemolizumab trials.
Kenji Shibuya
Kenji Shibuya (渋谷 健司) is a Japanese physician and global health policy researcher, known for the 2011 Lancet paper on what made Japan's population healthy.
Kennedy R. Lees
Kennedy R. Lees is a professor of cerebrovascular medicine at the University of Glasgow whose trials shaped thrombolysis for acute ischaemic stroke, including the 2010 Lancet pooled analysis.
Kenneth A. Arndt
Kenneth A. Arndt is an American dermatologist who was Dermatologist-in-Chief at Beth Israel Deaconess Medical Center for over two decades, edited Archives of Dermatology, and helped establish cutaneous laser surgery.
Kenneth A. Bauer
Kenneth A. Bauer is an American hematologist and Professor of Medicine at Harvard Medical School, based at Beth Israel Deaconess Medical Center in Boston, known for research on hypercoagulable states.
Kenneth A. Freedberg
Kenneth A. Freedberg is a Massachusetts General Hospital physician and Harvard professor who directs the Medical Practice Evaluation Center and leads the CEPAC cost-effectiveness model of HIV disease.
Kenneth A. Jacobson
Kenneth A. Jacobson is a medicinal chemist and pharmacologist who leads the Molecular Recognition Section at NIDDK, NIH, studying adenosine and P2Y receptor drug targets.